Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alignment Healthcare (ALHC) EPS (Weighted Average and Diluted) (2021 - 2025)

Alignment Healthcare's EPS (Weighted Average and Diluted) history spans 5 years, with the latest figure at -$0.05 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 68.75% year-over-year to -$0.05; the TTM value through Dec 2025 reached -$0.01, up 98.53%, while the annual FY2025 figure was -$0.0, 99.26% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.05 in Q4 2025 per ALHC's latest filing, down from $0.02 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.07 in Q2 2025 to a low of -$0.32 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.16, with a median of -$0.19 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): crashed 150.0% in 2023, then soared 153.85% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.27 in 2021, then decreased by 18.52% to -$0.32 in 2022, then grew by 21.87% to -$0.25 in 2023, then surged by 36.0% to -$0.16 in 2024, then soared by 68.75% to -$0.05 in 2025.
  • Per Business Quant, the three most recent readings for ALHC's EPS (Weighted Average and Diluted) are -$0.05 (Q4 2025), $0.02 (Q3 2025), and $0.07 (Q2 2025).